Singapore markets closed

Koninklijke Philips N.V. (PHG)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
19.980.00 (0.00%)
At close: 04:00PM EDT
19.98 0.00 (0.00%)
After hours: 04:09PM EDT

Koninklijke Philips N.V.

Philips Center
Amstelplein 2
Amsterdam 1096 BC
Netherlands
31 20 597 7777
https://www.philips.com

Sector(s)Healthcare
IndustryMedical Devices
Full-time employees69,656

Key executives

NameTitlePayExercisedYear born
Mr. Roy JakobsPresident, CEO & Chairman of the Board of Management3.85MN/A1974
Dr. Paulus A. Stoffels M.D., Ph.D.Independent Vice Chairman of Supervisory Board & Secretary183.35kN/A1962
Mr. Abhijit BhattacharyaExecutive VP, CFO & Member of the Board of Management2.35MN/A1961
Mr. Marnix J. van GinnekenExecutive VP, Chief ESG, Legal Officer & Member of the Board of Management1.8MN/A1973
Mr. Willem AppeloExecutive VP & COON/AN/A1964
Mr. Leandro MazzoniHead of Investor RelationsN/AN/AN/A
Heidi SichienExecutive VP & Chief People OfficerN/AN/A1974
Mr. Andy HoExecutive VP & Chief Market Leader of Philips Greater ChinaN/AN/A1961
Jan KimpenChief Medical OfficerN/AN/A1958
Mr. Pim PreesmanCountry Leader/ Health Systems Leader IndonesiaN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease. In addition, the company offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. Further, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions. The company has strategic partnership agreements with TriHealth, Northwell, and Atrium Health. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Corporate governance

Koninklijke Philips N.V.’s ISS governance QualityScore as of 1 April 2024 is 3. The pillar scores are Audit: 1; Board: 1; Shareholder rights: 5; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.